Filing Details

Accession Number:
0000950170-25-021487
Form Type:
13G Filing
Publication Date:
2025-02-13 19:00:00
Filed By:
Anson Investments
Company:
Universe Pharmaceuticals Inc. (NASDAQ:UPC)
Filing Date:
2025-02-14
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Anson Funds Management LP 0 782,327 9.9%
Anson Management GP LLC 0 782,327 9.9%
Tony Moore 0 782,327 9.9%
Anson Advisors Inc. 0 782,327 9.9%
Amin Nathoo 0 782,327 9.9%
Moez Kassam 0 782,327 9.9%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
Anson Funds Management LP
 
Signature:/s/ Tony Moore
Name/Title:Tony Moore Manager
Date:02/14/2025
 
Anson Management GP LLC
 
Signature:/s/ Tony Moore
Name/Title:Tony Moore Manager
Date:02/14/2025
 
Tony Moore
 
Signature:/s/ To come
Name/Title:To come
Date:02/14/2025
 
Anson Advisors Inc.
 
Signature:/s/ Amin Nathoo
Name/Title:Amin Nathoo Director
Date:02/14/2025
 
Signature:/s/ Moez Kassam
Name/Title:Moez Kassam Director
Date:02/14/2025
 
Signature:/s/ Amin Nathoo
Name/Title:Amin Nathoo
Date:02/14/2025
 
Signature:/s/ Moez Kassam
Name/Title:Moez Kassam
Date:02/14/2025
 
Amin Nathoo
 
Signature:/s/ To come
Name/Title:To come
Date:02/14/2025
 
Moez Kassam
 
Signature:/s/ To come
Name/Title:To come
Date:02/14/2025
Exhibit Information

Exhibit 99.1 Joint Filing Agreement dated February 14, 2025, by and among Anson Funds Management LP, Anson Management GP LLC, Mr. Moore, Anson Advisors Inc., Mr. Nathoo and Mr. Kassam.